Martin-Loeches I, Timsit JF, Kollef MH, Wunderink RG, et al. Clinical and microbiological outcomes, by causative pathogen, in the ASPECT-NP randomized, controlled, Phase 3 trial comparing ceftolozane/tazobactam and meropenem for treatment of hospital-acquired/ventilator-associated bacterial pneumonia. J Antimicrob Chemother 2022;77:1166-1177.
PMID: 35022730